Femoral Micropuncture or Routine Introducer Study (FEMORIS)
This study has been terminated.
(This original design is no longer consistent with current clinical practice.)
Sponsor:
Cook
Information provided by (Responsible Party):
Cook
ClinicalTrials.gov Identifier:
NCT01103141
First received: April 12, 2010
Last updated: February 7, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
FEMORIS is a marketing study approved by institutional review boards to compare the rates of complications found when using either the Micropuncture® needle introducer or a standard gauge-18 needle to access the groin blood vessels.
| Condition | Intervention |
|---|---|
|
Complications |
Device: Micropuncture needle set Device: Standard gauge-18 needle set |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Supportive Care |
Further study details as provided by Cook:
Primary Outcome Measures:
- Incidence of access site complications [ Time Frame: 7 - 14 days ] [ Designated as safety issue: Yes ]
| Enrollment: | 144 |
| Study Start Date: | June 2010 |
| Study Completion Date: | April 2011 |
| Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Micropuncture
Micropuncture
|
Device: Micropuncture needle set
Groin access for vascular intervention
|
|
Active Comparator: Standard
Standard
|
Device: Standard gauge-18 needle set
Groin access for vascular intervention
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Undergoing left heart catheterization with anticipated or possible percutaneous coronary intervention
Exclusion Criteria:
- Left heart cardiac catheterization purely for diagnostic purposes where percutaneous coronary intervention is not anticipated
- Catheterization utilizes primary vascular access site other than the groin
- Catheterization is intended for right heart procedure alone or combined with left and right heart procedures
- Age less than 18 years
- Patient has planned intervention or access utilizing the same groin within 14 days
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01103141
Locations
| United States, California | |
| University of California, San Francisco, Fresno, School of Medicine | |
| Fresno, California, United States, 93701 | |
| United States, Indiana | |
| St. Vincent Hospital | |
| Indianapolis, Indiana, United States, 46290 | |
Sponsors and Collaborators
Cook
More Information
No publications provided
| Responsible Party: | Cook |
| ClinicalTrials.gov Identifier: | NCT01103141 History of Changes |
| Other Study ID Numbers: | 09-012 |
| Study First Received: | April 12, 2010 |
| Last Updated: | February 7, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Cook:
|
Vascular Surgical Procedures Angioplasty Radiology, Interventional |
ClinicalTrials.gov processed this record on May 19, 2013